Calidi Biotherapeutics, Inc.

CLDI· NYSE

CLDI · Calidi Biotherapeutics, Inc. · Thaler

Calidi Biotherapeutics, Inc.

CLDI· NYSECore metricsCIK 1855485

FollowFollowing

Biological products, except diagnostic substances174 peers

Last sale: Oct 2, 2026 · +0.00%
Market cap: $2.77M; 2.58M shares
Filings: 406

Price

$1.07

Oct 2, 2026 · IEX last sale

IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$45.00K

FY 2022

Period	Ended	Value	Kind	Source trail
FY 2022	2022-12-31	$45,000	reported

Calidi Biotherapeutics, Inc. · CIK 1855485 · Engraved from SEC EDGAR